Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jack Y Prochnau

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Biomedicines|September 28, 2024
The Road Ahead in Pancreatic Cancer: Emerging Trends and Therapeutic ProspectsChris T P Do, Jack Y Prochnau, Angel Dominguez, et al.
Nucleic Acids Research|July 10, 2025
A tRNA gene potential to activate interferon signaling involves selective termination and is suppressible by La protein/SSBAlan C Kessler, Sandy Mattijssen, Gennady H Margolin, et al.
Journal of the American Chemical Society|November 1, 2019
Nucleolar Stress Induction by Oxaliplatin and DerivativesEmily C Sutton, Christine E McDevitt, Jack Y Prochnau, et al.
Molecular Cancer Therapeutics|June 26, 2025
Targeting DDR2 for Treating Pancreatic CancerChris Tp Do, Prabhakar Pitta Venkata, Jack Y Prochnau, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Biomedicines|September 28, 2024
The Road Ahead in Pancreatic Cancer: Emerging Trends and Therapeutic ProspectsChris T P Do, Jack Y Prochnau, Angel Dominguez, et al.
Nucleic Acids Research|July 10, 2025
A tRNA gene potential to activate interferon signaling involves selective termination and is suppressible by La protein/SSBAlan C Kessler, Sandy Mattijssen, Gennady H Margolin, et al.
Journal of the American Chemical Society|November 1, 2019
Nucleolar Stress Induction by Oxaliplatin and DerivativesEmily C Sutton, Christine E McDevitt, Jack Y Prochnau, et al.
Molecular Cancer Therapeutics|June 26, 2025
Targeting DDR2 for Treating Pancreatic CancerChris Tp Do, Prabhakar Pitta Venkata, Jack Y Prochnau, et al.
Pageof 1